Clinical Trial Update: A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study assessing a single dose of NNC0194-0499 in Chinese men with non-alcoholic fatty liver disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• NNC0194-0499

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Non-alcoholic Fatty Liver Disease | Phase 1 | Status: COMPLETED